European Archives - Page 9 of 1121 - European Medical Journal

Sjögren Disease Tied to 70% Higher Mortality Risk

A decade-long study has found that people with Sjögren disease are 70% more likely to die than the general population, with infections, cancer, and cardiovascular disease as the top causes.

Longevity Medicine

In this three-part series, Jonathan Sackier is joined by Rini Chatterjee, clinician, longevity expert, and Founder of Resilience Health. Together, they explore how functional medicine, biohacking, and evolutionary biology can be used to transform modern health care, improve health span, and prevent chronic disease.

Personalised Lighting Intervention Eases Fatigue in Patients with Cancer

A study involving 138 cancer patients found that a personalised lighting intervention, guided by wearable-tracked circadian rhythms, reduced fatigue and improved sleep, anxiety, and physical function.

New air cargo project links medicine and agriculture

The initiative is set to revolutionise healthcare delivery and agricultural exports in low- and middle-income countries.

Stark Inequalities in Infectious Disease Admissions Revealed

A new report from the UK Health Security Agency (UKHSA) highlights profound inequalities in infectious disease outcomes and hospital admissions across England.

Nutrition and Diabetes Policies Help Combat MASLD: EASL 2025

Timely public health policies targeting key metabolic conditions can reduce the global burden of MASLD.

Genetic Study Questions Alcohol’s Role in Fatty Liver: EASL 2025

The findings suggest that lifestyle factors beyond alcohol, such as diet and physical inactivity, may play a more substantial role in fatty liver development.

Lessons from Respiratory Viruses: Interview with Peter Openshaw

Peter Openshaw | Proconsul, Professor of Experimental Medicine, National Heart & Lung Institute – Faculty of Medicine, Imperial…

Diu Nguyen

Hema Now: Episode 16: A Journey Through Leukaemia Research

Diu Nguyen, Lecturer and Group Leader at the Centre for Haemato-Oncology, Barts Cancer Institute, joins the podcast to discuss breakthroughs in acute myeloid leukaemia (AML) research

SGLT2 Inhibitors Reduce Hyperkalaemia Risk in RAASi Use

SGLT2 inhibitors reduce hyperkalemia risk, aiding RAASi continuity in high-risk patients.